Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Human bone marrow adipocytes support complete myeloid and lymphoid differentiation from human CD34 cells.

Corre J., Planat-Benard V., Corberand JX., Pénicaud L., Casteilla L., Laharrague P.

Laboratory Study, published in Br J Haematol (2004) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Br J Haematol (2004)
Country
England
Reported sample size
—
Source database
PubMed
PMID
15491297
DOI
10.1111/j.1365-2141.2004.05198.x

Abstract (original English)

In humans, the role of bone marrow (BM) adipocytes in supporting haematopoiesis has been questioned. A co-culture system of CD34(+) cells seeded onto either BM undifferentiated mesenchymal stem cells or differentiated adipocytes showed that BM adipocytes did not support the maintenance of immature progenitors but enabled their complete differentiation along the myeloid and lymphoid pathways. These properties appear to be opposite to those of osteoblasts, although both cell types share a common mesenchymal progenitor. These results suggest that stromal cells play a variety of roles in the haematopoietic microenvironment, which could be significant in situations such as osteoporosis or ageing.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdultAgedAged, 80 and overAntigens, CD34Bone Marrow CellsCell DifferentiationCoculture TechniquesHumansLymphocytes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.